Compare Chandra Daya Investasi Tbk. (CDIA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chandra Daya Investasi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Chandra Daya Investasi Tbk. trades at Rp635 (market cap 79.27T, 22.37M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Chandra Daya Investasi Tbk. is far larger — about 473.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Chandra Daya Investasi Tbk. is more actively traded (22.37M versus 71K). Which is the better fit depends on your goals.
| CDIA | OBAT | |
|---|---|---|
Market Cap | 79.27T | 167.37B |
Volume | 22.37M | 71K |
Lot | 223.74K | 710 |
Turnover | 14.26B | 17.51M |
Average Price | 637.18 | 246.63 |
Value | 14.26B | 17.51M |
Indicative Equilibrium Price | 635 | 246 |
Indicative Equilibrium Volume | 3.37K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chandra Daya Investasi Tbk.
PT Chandra Daya Investasi Tbk. the (Company) was established based on Notarial Deed No. 26 dated February 8, 2023, of Jose Dirma Satria, S.H., M.Kn., Notary in Jakarta. The Company started its commercial operations in 2023. The Company is a subsidiary of PT Chandra Asri Pacific Tbk and belongs to a group of companies owned by PT Barito Pacific Tbk (Barito Pacific Group). Mr. Pajogo Pangestu is the ultimate beneficial owner of the Company.
Read more on CDIA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
